Correlation Between PAVmed Series and Lucid Diagnostics

Can any of the company-specific risk be diversified away by investing in both PAVmed Series and Lucid Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PAVmed Series and Lucid Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between PAVmed Series Z and Lucid Diagnostics, you can compare the effects of market volatilities on PAVmed Series and Lucid Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PAVmed Series with a short position of Lucid Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of PAVmed Series and Lucid Diagnostics.

Diversification Opportunities for PAVmed Series and Lucid Diagnostics

0.01

Correlation Coefficient

PAVmed Series  Lucid Diagnostics

Significant diversification

The 3 months correlation between PAVmed and Lucid is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding PAVmed Series Z and Lucid Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lucid Diagnostics and PAVmed Series is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PAVmed Series Z are associated (or correlated) with Lucid Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lucid Diagnostics has no effect on the direction of PAVmed Series i.e., PAVmed Series and Lucid Diagnostics go up and down completely randomly.

Pair Corralation between PAVmed Series and Lucid Diagnostics

Assuming the 90 days horizon PAVmed Series Z is expected to generate 21.9 times more return on investment than Lucid Diagnostics. However, PAVmed Series is 21.9 times more volatile than Lucid Diagnostics. It trades about 0.25 of its potential returns per unit of risk. Lucid Diagnostics is currently generating about -0.04 per unit of risk. If you would invest  2.59  in PAVmed Series Z on September 17, 2024 and sell it today you would earn a total of  0.29  from holding PAVmed Series Z or generate 11.2% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	46.15%
Values	Daily Returns

PAVmed Series Z  vs.  Lucid Diagnostics

PAVmed Series Z

Risk-Adjusted Performance

19 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in PAVmed Series Z are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak primary indicators, PAVmed Series showed solid returns over the last few months and may actually be approaching a breakup point.

Lucid Diagnostics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Lucid Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Pair Trading with PAVmed Series and Lucid Diagnostics

The main advantage of trading using opposite PAVmed Series and Lucid Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PAVmed Series position performs unexpectedly, Lucid Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lucid Diagnostics will offset losses from the drop in Lucid Diagnostics' long position.

The idea behind PAVmed Series Z and Lucid Diagnostics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.